Elevated glycoprotein acetyl levels in adolescence and early adulthood predict adverse cardiometabolic profiles and risk of metabolic syndrome in up to 10 year follow-up
View ORCID ProfileScott T. Chiesa, Marietta Charakida, Georgios Georgiopoulos, Justin D. Roberts, Simon J. Stafford, Chloe Park, Juha Mykkänen, Mika Kähönen, Terho Lehtimäki, Mika Ala-Korpela, Olli Raitakari, View ORCID ProfileAlun D. Hughes, Naveed Sattar, Nicholas J. Timpson, John E. Deanfield
doi: https://doi.org/10.1101/2020.09.30.20204479
Scott T. Chiesa
1Institute of Cardiovascular Science, University College London, London, UK
PhDMarietta Charakida
2Department of Imaging Science and Biomedical Engineering, King’s College London, London, UK
MDGeorgios Georgiopoulos
2Department of Imaging Science and Biomedical Engineering, King’s College London, London, UK
MDJustin D. Roberts
3Cambridge Centre for Sport and Exercise Sciences, Anglia Ruskin University, Cambridge, UK
PhDSimon J. Stafford
4Molecular Diagnostics Unit, Medical Technology Research Centre, Faculty of Health, Education, Medicine & Social Care, Anglia Ruskin University, Chelmsford, UK
PhDChloe Park
5Cardiometabolic Phenotyping Group, Institute of Cardiovascular Science, University College London, UK
PhDJuha Mykkänen
6Research Centre of Applied and Preventive Cardiovascular Medicine, University of Turku, Turku, Finland
7Centre for Population Health Research, University of Turku and Turku University Hospital, Finland
PhDMika Kähönen
8Department of Clinical Physiology, Tampere University Hospital, Tampere, Finland
9Finnish Cardiovascular Research Center Tampere, Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland
PhDTerho Lehtimäki
9Finnish Cardiovascular Research Center Tampere, Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland
10Department of Clinical Chemistry, Fimlab Laboratories, Tampere, Finland
MDMika Ala-Korpela
11Computational Medicine, Faculty of Medicine, University of Oulu and Biocenter Oulu, Oulu, Finland
12Center for Life Course Health Research, University of Oulu, Oulu, Finland
13NMR Metabolomics Laboratory, School of Pharmacy, University of Eastern Finland, Kuopio, Finland
PhDOlli Raitakari
6Research Centre of Applied and Preventive Cardiovascular Medicine, University of Turku, Turku, Finland
7Centre for Population Health Research, University of Turku and Turku University Hospital, Finland
14Department of Clinical Physiology and Nuclear Medicine, Turku University Hospital, Turku, Finland
MDAlun D. Hughes
5Cardiometabolic Phenotyping Group, Institute of Cardiovascular Science, University College London, UK
15MRC Unit for Lifelong Health and Ageing, University College London, London, UK
PhDNaveed Sattar
16Institute of Cardiovascular and Medical Sciences, British Heart Foundation (BHF) Glasgow Cardiovascular Research Centre, University of Glasgow, UK
MDNicholas J. Timpson
17Population Health Sciences, Bristol Medical School, Faculty of Health Sciences, University of Bristol, UK
18Medical Research Council Integrative Epidemiology Unit, University of Bristol, UK
PhDJohn E. Deanfield
1Institute of Cardiovascular Science, University College London, London, UK
FRCP
Posted September 30, 2020.
Elevated glycoprotein acetyl levels in adolescence and early adulthood predict adverse cardiometabolic profiles and risk of metabolic syndrome in up to 10 year follow-up
Scott T. Chiesa, Marietta Charakida, Georgios Georgiopoulos, Justin D. Roberts, Simon J. Stafford, Chloe Park, Juha Mykkänen, Mika Kähönen, Terho Lehtimäki, Mika Ala-Korpela, Olli Raitakari, Alun D. Hughes, Naveed Sattar, Nicholas J. Timpson, John E. Deanfield
medRxiv 2020.09.30.20204479; doi: https://doi.org/10.1101/2020.09.30.20204479
Elevated glycoprotein acetyl levels in adolescence and early adulthood predict adverse cardiometabolic profiles and risk of metabolic syndrome in up to 10 year follow-up
Scott T. Chiesa, Marietta Charakida, Georgios Georgiopoulos, Justin D. Roberts, Simon J. Stafford, Chloe Park, Juha Mykkänen, Mika Kähönen, Terho Lehtimäki, Mika Ala-Korpela, Olli Raitakari, Alun D. Hughes, Naveed Sattar, Nicholas J. Timpson, John E. Deanfield
medRxiv 2020.09.30.20204479; doi: https://doi.org/10.1101/2020.09.30.20204479
Subject Area
Subject Areas
- Addiction Medicine (324)
- Allergy and Immunology (627)
- Anesthesia (163)
- Cardiovascular Medicine (2372)
- Dermatology (206)
- Emergency Medicine (379)
- Epidemiology (11768)
- Forensic Medicine (10)
- Gastroenterology (702)
- Genetic and Genomic Medicine (3738)
- Geriatric Medicine (350)
- Health Economics (633)
- Health Informatics (2395)
- Health Policy (932)
- Hematology (341)
- HIV/AIDS (782)
- Medical Education (365)
- Medical Ethics (104)
- Nephrology (398)
- Neurology (3501)
- Nursing (198)
- Nutrition (525)
- Oncology (1823)
- Ophthalmology (537)
- Orthopedics (219)
- Otolaryngology (287)
- Pain Medicine (232)
- Palliative Medicine (66)
- Pathology (446)
- Pediatrics (1033)
- Primary Care Research (420)
- Public and Global Health (6139)
- Radiology and Imaging (1280)
- Respiratory Medicine (826)
- Rheumatology (379)
- Sports Medicine (323)
- Surgery (402)
- Toxicology (50)
- Transplantation (172)
- Urology (145)